## Abstract In vivo response to initial therapy, as assessed by determination of minimal residual disease (MRD) after 5 and 12 weeks of treatment, has evolved as a strong prognostic factor in children with acute lymphoblastic leukemia (ALL) treated according to the BFM regime. Individual treatment
Modification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemia
✍ Scribed by Guérin, E; Entz-Werlé, N; Eyer, D; Pencreac'h, E; Schneider, A; Falkenrodt, A; Uettwiller, F; Babin, A; Voegeli, A-C; Lessard, M
- Book ID
- 110055330
- Publisher
- Nature Publishing Group
- Year
- 2003
- Tongue
- English
- Weight
- 143 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The tuberous sclerosis (TSC) genes, TSC1 and TSC2, encode hamartin and tuberin, respectively, and are putative tumor suppressor genes that were originally identified due to their involvement in the inherited autosomal dominant disorder tuberous sclerosis. It has been elucidated that the two proteins
It is widely accepted that pathogenesis of childhood acute lymphoblastic leukemia (ALL) is related to the interplay between specific environmental exposure and inherited background. Major role of some members of the ATP-binding cassette (ABC) family of membrane transporters including MDR1 (ABCB1, P-